SE456316B - Steril, isoton vattenlosning med plasmaexpanderande verkan, innehallande ett raffinerat pullulan, samt forfarande for framstellning derav - Google Patents

Steril, isoton vattenlosning med plasmaexpanderande verkan, innehallande ett raffinerat pullulan, samt forfarande for framstellning derav

Info

Publication number
SE456316B
SE456316B SE8003850A SE8003850A SE456316B SE 456316 B SE456316 B SE 456316B SE 8003850 A SE8003850 A SE 8003850A SE 8003850 A SE8003850 A SE 8003850A SE 456316 B SE456316 B SE 456316B
Authority
SE
Sweden
Prior art keywords
pullulan
refined
pul
plasma
molecular weight
Prior art date
Application number
SE8003850A
Other languages
English (en)
Swedish (sv)
Other versions
SE8003850L (sv
Inventor
T Igarashi
K Nomura
K Naito
M Yoshida
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Publication of SE8003850L publication Critical patent/SE8003850L/
Publication of SE456316B publication Critical patent/SE456316B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
SE8003850A 1979-05-25 1980-05-22 Steril, isoton vattenlosning med plasmaexpanderande verkan, innehallande ett raffinerat pullulan, samt forfarande for framstellning derav SE456316B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54063976A JPS6049164B2 (ja) 1979-05-25 1979-05-25 血漿増量剤

Publications (2)

Publication Number Publication Date
SE8003850L SE8003850L (sv) 1980-11-26
SE456316B true SE456316B (sv) 1988-09-26

Family

ID=13244813

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8003850A SE456316B (sv) 1979-05-25 1980-05-22 Steril, isoton vattenlosning med plasmaexpanderande verkan, innehallande ett raffinerat pullulan, samt forfarande for framstellning derav

Country Status (7)

Country Link
US (1) US4370472A (de)
JP (1) JPS6049164B2 (de)
DE (1) DE3019895A1 (de)
FR (1) FR2458286A1 (de)
GB (1) GB2052975B (de)
IT (1) IT1130734B (de)
SE (1) SE456316B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2517326B1 (fr) * 1981-12-01 1989-09-01 Hayashibara Biochem Lab Production d'une preparation de pullulane a repartition etroite de masses moleculaires
US4913925A (en) * 1982-10-25 1990-04-03 Yasutake Hiji Foodstuff containing a hyperglycemia controlling agent
JPS5974976A (ja) * 1982-10-25 1984-04-27 Yasutake Hichi 血糖値上昇抑制剤を添加した飲食物
JPS62236469A (ja) * 1986-04-04 1987-10-16 Yasutake Hichi 低カロリ−飲食物
US6746836B1 (en) * 2000-12-08 2004-06-08 Abe Widra Alpha-keratose as a blood plasma expander and use thereof
JP5860480B2 (ja) 2011-01-11 2016-02-16 キャプシュゲル・ベルジウム・エヌ・ヴィ プルランを含む新しい硬カプセル
WO2018189587A1 (en) 2017-04-14 2018-10-18 Capsugel Belgium Nv Process for making pullulan
CN110678170A (zh) 2017-04-14 2020-01-10 比利时胶囊公司 普鲁兰多糖胶囊

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1096850B (de) * 1959-07-24 1961-01-12 Hoechst Ag Verfahren zur Gewinnung eines dextranaehnlichen Polysaccharids aus Pullularia pullulans
JPS5142199B2 (de) * 1972-09-04 1976-11-13

Also Published As

Publication number Publication date
FR2458286A1 (fr) 1981-01-02
IT1130734B (it) 1986-06-18
US4370472A (en) 1983-01-25
GB2052975A (en) 1981-02-04
JPS55157513A (en) 1980-12-08
DE3019895A1 (de) 1980-11-27
IT8022285A0 (it) 1980-05-23
GB2052975B (en) 1983-09-07
SE8003850L (sv) 1980-11-26
JPS6049164B2 (ja) 1985-10-31
DE3019895C2 (de) 1987-10-29
FR2458286B1 (de) 1983-11-04

Similar Documents

Publication Publication Date Title
Morita et al. Nail-patella syndrome: Light and electron microscopic studies of the kidney
Whipple et al. Fibrinogen of the blood as influenced by the liver necrosis of chloroform poisoning
Kurrein Cerebral mucormycosis
SE456316B (sv) Steril, isoton vattenlosning med plasmaexpanderande verkan, innehallande ett raffinerat pullulan, samt forfarande for framstellning derav
Barnard, PJ & Kibel The haemolytic-uraemic syndrome of infancy and childhood: a report of eleven cases
DE2459915B2 (de) Aktive Verbindung des Plasminogen-Typs, Verfahren zu ihrer Reinigung und ihre Verwendung
DE2734150A1 (de) Verfahren zur gewinnung von human- lysozym
CN113440532A (zh) 一种褐藻寡糖的应用
Craig et al. A familial metabolic disorder with storage of an unusual polysaccharide complex
Padmanabhan et al. Effect of pre-treatment with aspirin on alcohol-induced neural tube defects in the TO mouse fetuses
DE2605576C3 (de) Verfahren zum Isolieren der Proteasen Papain,,Chimopapain, Lysozym und Proteinase X aus dem Milchsaft von Carica papya und Verwendung der isolierten Proteasen zur Herstellung von sterilisierten und Iyophilisirten orthopädischen, neurochirurgischen oder ophthalmologischen Präparaten
Grossman et al. Effect of heparin on fate of intravenously administered fat emulsions in rats.
Willcox Toxic jaundice
US4024247A (en) Composition and method of using a protein mixture derived from liver
DE2409650C3 (de) Verwendung wäßriger Lösung von menschlichem Serum-Haptoglobin bei der Bekämpfung von hämolytischen Nierenstörungen
Wynn et al. Chromatographic observations on nitrogenous constituents of petroleum-ether extracts of plasma
US2143475A (en) Therapeutic agent
JP3769045B2 (ja) 抗炎症剤
Evans Anaemia associated with the sickle cell trait in British West African natives
JP2889491B2 (ja) 血圧降下剤
DE1617279A1 (de) Verfahren zur Herstellung pharmazeutischer Praeparate zur Verhinderung der Bildung von Blutgerinnseln
JP2005532992A (ja) 肝炎治療剤及び予防剤または肝臓保護剤として有用なソムオガルピ（ＡｃａｎｔｈｏｐａｎａｘＫｏｒｅａｎｕｍ）抽出物
Rutishauser Effects of bile salts on the motor activity of the guinea‐pig gall‐bladder in vitro
DE1767099B1 (de) Verfahren zur Gewinnung eines Glykoproteins mit einer Hemmwirkung gegenueber Magensaeureabsonderung und einer Antiaktivitaet gegenueber Ulcus-Bildung
Coimbra et al. Effect of urinary alkalinization on renal changes produced by cationic albumin

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8003850-8

Effective date: 19911209

Format of ref document f/p: F